Brussels, 7 October 2013: A report published today shows that European research and development (R&D) investments in health have stagnated since 2010, and this is the first time after decades of annual increases. The report was commissioned by Janssen Pharmaceutica NV and the research was conducted by Deloitte Health Economics group.
- The report-“Investing in European Health R&D"
- Presentation slides Jane Griffiths
- Investing in European health R&D – Press Release 7 October 2013
- Backgrounder on Janssen research initiatives and collaboration
- Report Executive Summary - Investing in European health R&D
- Graph: R&D Distribution and intensity by sector in the European Union
- Graph: Total health-related R&D in Europe in 2011
- Graph: Private (2011) and Public (2010) health-related R&D expenditures per country
- Graph: Evolution total health-related R&D 2004-2011 in EU and US
Source : Janssen health policy centre
